Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1160/week)
    • Manufacturing(569/week)
    • Technology(1126/week)
    • Energy(390/week)
    • Other Manufacturing(349/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Biohaven Pharmaceutical Holding Company Ltd.

Feb 23, 2021
Biohaven To Report Fourth Quarter And Full Year 2020 Financial Results And Recent Business Developments On March 1, 2021
Feb 22, 2021
Biohaven's BHV-1200, A Multimodal Antibody Therapy Enhancer (MATE), Demonstrates Effective Neutralization Of Multiple Strains Of COVID-19
Feb 08, 2021
Biohaven Provides Update On ESG Practices
Jan 25, 2021
Biohaven Announces Preliminary 4Q2020 Net Product Revenue For NURTEC® ODT
Jan 18, 2021
Biohaven Signs Cody Ware as Driver for Nurtec® ODT Chevrolet for the 2021 NASCAR Cup Series Season
Jan 18, 2021
Biohaven Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program
Jan 07, 2021
Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs
Jan 05, 2021
Biohaven's Nurtec® ODT Partners with Rick Ware Racing for 24 Hours of Daytona Entry
Dec 16, 2020
Biohaven's Rimegepant For Preventive Treatment Of Migraine Published In The Lancet
Dec 02, 2020
Biohaven's Nurtec(TM) ODT Partners with the Rick Ware Racing Team in the 2021 NASCAR Cup Series
Nov 16, 2020
Biohaven Pharmaceuticals And Weill Cornell Medicine Collaborate To Initiate Proof Of Concept Trial With CGRP Receptor Antagonist In Plaque Psoriasis
Nov 11, 2020
Biohaven Pharmaceuticals Inaugural Partner Of National Ataxia Foundation's Drug Development Collaborative
Nov 09, 2020
Biohaven Reports Third Quarter 2020 Financial Results and Recent Business Developments
Oct 30, 2020
Biohaven To Report Third Quarter 2020 Financial Results And Recent Business Developments On November 9, 2020
Oct 14, 2020
U.S. FDA Accepts Biohaven's Supplemental New Drug Application (sNDA) Of NURTEC(TM) ODT For The Preventive Treatment Of Migraine
Sep 28, 2020
BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region
Sep 10, 2020
Biohaven's Oral Zavegepant, A Third Generation CGRP Receptor Antagonist, Receives Authorization To Proceed From FDA And Achieves First In Human Dosing
Aug 10, 2020
Biohaven Reports Second Quarter 2020 Financial Results And Recent Business Developments
Aug 07, 2020
Biohaven Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street
Aug 03, 2020
Biohaven Announces Enrollment Of First Patients In Pivotal HEALEY ALS Platform Trial Including Verdiperstat Conducted By Healey Center For ALS At Massachusetts General Hospital
  •  
  • Page 1
  • ››

Latest News

Jun 13, 2025

NOG Prices Upsized $175.0 Million Reopening of 3.625% Convertible Senior Notes Due 2029

Jun 13, 2025

Oklo Inc. Announces Pricing of Public Offering of Common Stock

Jun 13, 2025

AIRO Announces Pricing of Its Initial Public Offering

Jun 13, 2025

SINOVAC’s Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and...

Jun 13, 2025

Perma-Pipe International Holdings, Inc. Announces the Departure of David Mansfield and the Appointment of...

Jun 13, 2025

L'Otan booste ses dépenses, mais l'Europe saura-t-elle produire plus d'armes?

Jun 13, 2025

As NATO ups defence spending, can Europe produce the weapons?

Jun 13, 2025

Iran airspace closed until further notice: state TV

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia